Loading…

Evipro will build a production facility for hemostatic materials and endovascular surgery medical devices in the Koltsovo biotechnopark in Novosibirsk, Russia. Total investment is RUB 350 million over five years, with construction expected to take one year and full capacity in three years.
“Общая сумма инвестиций в проект составляет 350 млн рублей на ближайшие пять лет”vademec.ru
Summarized from public sources; check the original articles before acting on it.